XML 19 R25.htm IDEA: XBRL DOCUMENT
v2.4.0.6

Share-Based Compensation (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2012
Share-Based Compensation [Abstract] |
Certain information related to stock options and non-vested shares |
|  | Three Months Ended September 30, 2012 |
|  | Stock Options |  |  | Restricted Stock |
|  | Number of Shares |  |  | Weighted Average Exercise Price |  |  | Aggregate Intrinsic Value |  |  | Weighted Average Remaining Term (Years) |  |  | Number of Shares |  |  | Weighted Average Grant Date Fair Value |
Outstanding as of June 30, 2012 |  |  | 6,485 |  |  | $ | 4.87 |  |  |  |  |  |  |  |  |  |  |  | 502 |  |  | $ | 5.66 |
Granted |  |  | 500 |  |  |  | 3.51 |  |  |  |  |  |  |  |  |  |  |  | 650 |  |  |  | 3.37 |
Forfeited |  |  | (30 | ) |  |  | 4.70 |  |  |  |  |  |  |  |  |  |  |  | — |  |  |  | — |
Exercised (1) |  |  | (50 | ) |  |  | 2.31 |  |  |  |  |  |  |  |  |  |  |  | n/a |  |  |  | n/a |
Vested |  |  | n/a |  |  |  | n/a |  |  |  |  |  |  |  |  |  |  |  | — |  |  |  | — |
Expired |  |  | (1,575 | ) |  |  | 6.50 |  |  |  |  |  |  |  |  |  |  |  | n/a |  |  |  | n/a |
Outstanding as of September 30, 2012 (2) |  |  | 5,330 |  |  | $ | 4.29 |  |  | $ | 1,017 |  |  |  | 3.2 |  |  |  | 1,152 |  |  | $ | 4.37 |
Exercisable as of September 30, 2012 |  |  | 4,417 |  |  | $ | 4.34 |  |  | $ | 847 |  |  |  | 2.5 |  |  |  |  |  |  |  |  |
|  | Nine Months Ended September 30, 2012 |
|  | Stock Options |  |  | Restricted Stock |
|  | Number of Shares |  |  | Weighted Average Exercise Price |  |  | Aggregate Intrinsic Value |  |  | Weighted Average Remaining Term (Years) |  |  | Number of Shares |  |  | Weighted Average Grant Date Fair Value |
Outstanding as of December 31, 2011 |  |  | 6,720 |  |  | $ | 4.78 |  |  |  |  |  |  |  |  |  |  |  | 801 |  |  | $ | 5.67 |
Granted |  |  | 500 |  |  |  | 3.51 |  |  |  |  |  |  |  |  |  |  |  | 650 |  |  |  | 3.37 |
Forfeited |  |  | (30 | ) |  |  | 4.70 |  |  |  |  |  |  |  |  |  |  |  | — |  |  |  | — |
Exercised (1) |  |  | (285 | ) |  |  | 2.35 |  |  |  |  |  |  |  |  |  |  |  | n/a |  |  |  | n/a |
Vested |  |  | n/a |  |  |  | n/a |  |  |  |  |  |  |  |  |  |  |  | (299 | ) |  |  | 5.69 |
Expired |  |  | (1,575 | ) |  |  | 6.50 |  |  |  |  |  |  |  |  |  |  |  | n/a |  |  |  | n/a |
Outstanding as of September 30, 2012 (2) |  |  | 5,330 |  |  | $ | 4.29 |  |  | $ | 1,017 |  |  |  | 3.2 |  |  |  | 1,152 |  |  | $ | 4.37 |
Exercisable as of September 30, 2012 |  |  | 4,417 |  |  | $ | 4.34 |  |  | $ | 847 |  |  |  | 2.5 |  |  |  |  |  |  |  |  |
(1) | Unless otherwise specified, such as in the case of the exercise of stock options, the per share prices were determined using the closing price of the Company’s Common Stock as quoted on the NYSE MKT LLC. Shares issued upon exercise of options represent original issuances in private transactions pursuant to Section 4(2) of the Securities Act of 1933, as amended.
(2) | All shares outstanding as of September 30, 2012 are expected to vest.
n/a - Not applicable
Certain information regarding the Company's stock-based compensation |
|  | Three Months Ended September 30, |  |  | Nine Months Ended September 30, |
|  | 2012 |  |  | 2011 |  |  | 2012 |  |  | 2011 |
Compensation expense: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stock options |  | $ | 246 |  |  | $ | 501 |  |  | $ | 892 |  |  | $ | 957 |
Restricted stock |  |  | 621 |  |  |  | 468 |  |  |  | 1,667 |  |  |  | 931 |
Total |  | $ | 867 |  |  | $ | 969 |  |  | $ | 2,559 |  |  | $ | 1,888 |
Deferred tax benefits: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stock options |  | $ | 95 |  |  | $ | 193 |  |  | $ | 344 |  |  | $ | 369 |
Restricted stock |  |  | 88 |  |  |  | — |  |  | $ | 380 |  |  |  | — |
Total |  | $ | 183 |  |  | $ | 193 |  |  | $ | 724 |  |  | $ | 369 |
Realized tax benefits: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stock options |  | $ | 27 |  |  | $ | — |  |  | $ | 168 |  |  | $ | — |
Restricted stock |  |  | — |  |  |  | — |  |  |  | 291 |  |  |  | — |
Total |  | $ | 27 |  |  | $ | — |  |  | $ | 459 |  |  | $ | — |
Excess tax benefits(shortfall): |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stock options |  | $ | (1,693 | ) |  | $ | — |  |  | $ | (1,623 | ) |  | $ | — |
Restricted stock |  |  | — |  |  |  | — |  |  |  | (142 | ) |  |  | — |
Total |  | $ | (1,693 | ) |  | $ | — |  |  | $ | (1,765 | ) |  | $ | — |
Weighted average fair value per share: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stock option grants |  | $ | 0.87 |  |  | $ | — |  |  | $ | 0.87 |  |  | $ | 1.67 |
Restricted stock grants |  | $ | 3.37 |  |  | $ | — |  |  | $ | 3.37 |  |  | $ | 5.61 |
Intrinsic value of options exercised |  | $ | 70 |  |  | $ | — |  |  | $ | 437 |  |  | $ | — |
Fair value of restricted stock vested |  | $ | — |  |  | $ | — |  |  | $ | 1,164 |  |  | $ | 540 |
Cash received for strike price and tax withholdings |  | $ | 134 |  |  | $ | — |  |  | $ | 652 |  |  | $ | — |
Shares acquired through cashless exercise (1) |  |  | — |  |  |  | — |  |  |  | 147 |  |  |  | — |
Value of shares acquired |  | $ | — |  |  | $ | — |  |  | $ | 583 |  |  | $ | — |
(1) | All shares acquired represent shares tendered to cover the exercise price for options and tax withholdings on the intrinsic value of options exercised or restricted stock vested. These shares have been cancelled by the Company.
Unrecognized compensation expense and the weighted average period |
|  | As of September 30, 2012 |
|  | Stock Options |  |  | Restricted Stock |
Unrecognized expense |  | $ | 1,120 |  |  | $ | 3,711 |
Weighted average remaining years |  |  | 1.18 |  |  |  | 1.71 |

X
- Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of share-based compensation plans that may be presented in a single table for outstanding, vested and expected to vest, and exercisable awards. The information that may be disclosed in this table may include, but is not limited to, number of shares, weighted average exercise price, weighted average remaining contractual life, and aggregate intrinsic value. + References No definition available. + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the number and weighted-average exercise prices (or conversion ratios) for share options (or share units) that were outstanding at the beginning and end of the year, vested and expected to vest, exercisable or convertible at the end of the year, and the number of share options or share units that were granted, exercised or converted, forfeited, and expired during the year. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the total compensation cost related to nonvested awards not yet recognized and the weighted-average period over which it is expected to be recognized. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (i) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 + Details
Name: | us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration